We evaluated flow cytometric (FCM) analysis of transferrin receptor (T
FR) expression as a marker for the malignant potential in transitional
cell carcinoma (TCC). TCCs from 55 patients were analyzed by FCM usin
g an anti-TFR monoclonal antibody (CD71) and a TCC-specific monoclonal
antibody (EH14), which recognizes most TCC cells irrespective of the
grade. The cells were divided into subpopulations according to DNA plo
idy determined simultaneously. TFR expression correlated well with the
grade and the stage of the tumors. TFR expression of the aneuploid tu
mors was significantly higher than that of the euploid tumors in all s
ubpopulations. EH14 expression did not correlate with the grade or the
stage of the tumors. EH14 expression of the aneuploid tumors was sign
ificantly higher than that of the euploid tumors in the whole cell pop
ulation but not in the subpopulations. In moderately differentiated tu
mors or in T1 tumors, TFR expression was higher in multiple or recurre
nt tumors than in simple tumors. The cell size or shape were not the p
rimary reasons for the enhanced expression of TFR in the high-grade or
the high-stage tumors; instead, overproduction of TFR may take place
in these tumors. Clinically, many of the TCC tumors are grouped into G
2 or T1 tumors, some of which will be invasive cancers. Quantitative a
nalysis of TFR expression using FCM may be useful to predict the progn
osis of these tumors.